There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:C12N9/22
Jump to navigation
Jump to search
Subcategories
This category has the following 51 subcategories, out of 51 total.
A
B
C
D
F
G
I
J
L
M
N
O
P
R
S
T
V
X
Y
Pages in category "C12N9/22"
The following 134 pages are in this category, out of 134 total.
1
- 17273688. BASE EDITING FOR TREATING HUTCHINSON-GILFORD PROGERIA SYNDROME simplified abstract (Vanderbilt University)
- 17300668. METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES (Massachusetts Institute of Technology)
- 17300668. METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES (President and Fellows of Harvard College)
- 17735222. POLYPEPTIDE VARIANTS simplified abstract (The Procter & Gamble Company)
- 17767777. METHODS AND COMPOSITIONS FOR PRIME EDITING RNA (President and Fellows of Harvard College)
- 17795819. BASE EDITORS, COMPOSITIONS, AND METHODS FOR MODIFYING THE MITOCHONDRIAL GENOME (University of Washington)
- 17928516. QPT GENE ENGINEERED PLANT CELL AND USING METHOD OF THE SAME simplified abstract (KT&G CORPORATION)
- 17999756. COMPOSITIONS AND METHODS FOR GENE EDITING simplified abstract (The Regents of the University of California)
- 18007439. GENE CORRECTION FOR SCID-X1 IN LONG-TERM HEMATOPOIETIC STEM CELLS simplified abstract (THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY)
- 18064738. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES simplified abstract (President and Fellows of Harvard College)
- 18104640. METHODS AND KITS FOR IDENTIFYING CANCER TREATMENT TARGETS simplified abstract (The Regents of the University of California)
- 18130199. RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18130202. RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18167598. Compositions and Methods of Treating Ocular Diseases simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18234690. RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX simplified abstract (Massachusetts Institute of Technology)
- 18246420. PRIME EDITING-BASED GENE EDITING COMPOSITION WITH ENHANCED EDITING EFFICIENCY AND USE THEREOF simplified abstract (KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION)
- 18246420. PRIME EDITING-BASED GENE EDITING COMPOSITION WITH ENHANCED EDITING EFFICIENCY AND USE THEREOF simplified abstract (SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION)
- 18272355. HIV Pseudovirus Particles and Method for Preparing the Same simplified abstract (BOE Technology Group Co., Ltd.)
- 18273579. MODULATION OF A PATHOGENIC PHENOTYPE IN TH1 CELLS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18279034. STRATEGIES TO DEVELOP GENOME EDITING SPHERICAL NUCLEIC ACIDS (SNAS) simplified abstract (NORTHWESTERN UNIVERSITY)
- 18282421. Compositions and Methods for the Treatment of Conditions Associated with Nucleotide Repeat Expansion simplified abstract (The General Hospital Corporation)
- 18286984. PROMOTERS FOR VIRAL-BASED GENE THERAPY (The Regents of the University of California)
- 18289219. NOVEL AAV SEROTYPES DERIVED FROM A LIBRARY SCREEN simplified abstract (The Regents of the University of California)
- 18295036. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation)
- 18298942. SYNTHETIC TRANSCRIPTION FACTORS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18324928. CRISPR ENABLED MULTIPLEXED GENOME ENGINEERING simplified abstract (THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE)
- 18352037. FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS simplified abstract (Duke University)
- 18449940. DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS simplified abstract (Massachusetts Institute of Technology)
- 18459484. METHODS AND COMPOSITIONS FOR GENERATING COMPLEX TRAIT LOCI simplified abstract (PIONEER HI-BRED INTERNATIONAL, INC.)
- 18463589. TARGETED NON-VIRAL DNA INSERTIONS simplified abstract (The Regents of the University of California)
- 18472881. RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY simplified abstract (Duke University)
- 18547445. IN VIVO CRISPR SCREENING SYSTEM FOR DISCOVERING THERAPEUTIC TARGETS IN CD8 T CELLS (The Trustees of the University of Pennsylvania)
- 18551975. GENE CORRECTION FOR RAG2 DEFICIENCY IN HUMAN STEM CELLS simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 18556857. NEGATIVE-STRAND RNA VIRAL VECTOR AND PLANT GENOME EDITING METHOD WITHOUT TRANSFORMATION simplified abstract (Zhejiang University)
- 18558052. MULTIPLEXED UNBIASED NUCLEIC ACID AMPLIFICATION METHOD simplified abstract (Becton, Dickinson and Company)
- 18558122. MULTICOMPONENT XNAZYME-BASED NUCLEIC ACID DETECTION SYSTEM simplified abstract (The Regents of the University of California)
- 18558992. COMPOSITIONS COMPRISING NULLOMERS AND METHODS OF USING THE SAME FOR CANCER DETECTION AND DIAGNOSIS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18608561. METHODS AND COMPOSITIONS FOR SENSITIZATION OF TUMOR CELLS TO IMMUNE THERAPY simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18618668. CLASS 2 CRISPR/CAS COMPOSITIONS AND METHODS OF USE simplified abstract (The Regents of the University of California)
- 18641299. ADENOSINE NUCLEOBASE EDITORS AND USES THEREOF (President and Fellows of Harvard College)
- 18658077. METHODS OF TREATING MITOCHONDRIAL DISORDERS simplified abstract (The Regents of the University of California)
- 18658138. METHODS OF TREATING MITOCHONDRIAL DISORDERS simplified abstract (The Regents of the University of California)
- 18660923. COMPOSITIONS AND METHODS FOR IMPROVED GENOME EDITING WITH NME2CAS9 AND NME2-SMUCAS9 VARIANTS (University of Massachusetts)
- 18704681. CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR KNOCKING OUT C5 (Regeneron Pharmaceuticals, Inc.)
- 18706301. SERINE RECOMBINASES (The Board of Trustees of the Leland Stanford Junior University)
- 18706301. SERINE RECOMBINASES (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18709939. MODULATION OF THE CRISPR ROADBLOCK (CORNELL UNIVERSITY)
- 18715587. SELF-ASSEMBLING VIRUS-LIKE PARTICLES FOR DELIVERY OF PRIME EDITORS AND METHODS OF MAKING AND USING SAME (President and Fellows of Harvard College)
- 18724911. METHODS FOR IMPROVING PROTEIN DELIVERY TO PLANT CELLS BY BIOLISTICS (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18729647. CRISPR-MEDIATED DELETION OF FLI1 IN NK CELLS (The Regents of the University of California)
- 18732559. EVOLVED CAS9 PROTEINS FOR GENE EDITING (President and Fellows of Harvard College)
- 18744175. COMPOSITIONS AND METHODS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY (SMA) simplified abstract (Beam Therapeutics Inc.)
- 18751730. Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18795872. Streptococcus Canis Cas9 as a Genome Engineering Platform with Novel PAM Specificity (Massachusetts Institute of Technology)
- 18814007. SPLIT-LUCIFERASE REPORTER SYSTEMS, COLOR-CODED BEAD MULTIPLEX CRISPR SYSTEMS, AND METHODS OF USE THEREOF IN CRISPR-CAS BASED DIAGNOSTICS (Massachusetts Institute of Technology)
- 18814007. SPLIT-LUCIFERASE REPORTER SYSTEMS, COLOR-CODED BEAD MULTIPLEX CRISPR SYSTEMS, AND METHODS OF USE THEREOF IN CRISPR-CAS BASED DIAGNOSTICS (President and Fellows of Harvard College)
- 18898412. PROBES FOR DEPLETING ABUNDANT SMALL NONCODING RNA (ILLUMINA, INC.)
- 18927415. AAV VECTORS ENCODING BASE EDITORS AND USES THEREOF (President and Fellows of Harvard College)
- 18948601. ENGINEERED PNMA PROTEINS AND DELIVERY SYSTEMS THEREOF (Massachusetts Institute of Technology)
- 18957358. MITOCHONDRIAL BASE EDITORS AND METHODS FOR EDITING MITOCHONDRIAL DNA (President and Fellows of Harvard College)
- 18962390. SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE) (MASSACHUSETTS INSTITUTE OF TECHNOLOGY)
2
- 20240008460. JAK3 GENE-MUTATED, SEVERE COMBINED IMMUNODEFICIENCY ANIMAL MODEL AND CONSTRUCTION METHOD THEREFOR simplified abstract (KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY)
- 20240008461. CRUCIAN CARP (CARASSIUS AURATUS) STRAIN WITHOUT INTERMUSCULAR BONES AND BREEDING METHOD THEREOF simplified abstract (HEILONGJIANG RIVER FISHERIES RESEARCH INSTITUTE OF CHINESE ACADEMY OF FISHERY SCIENCES)
A
- Accessibility patent applications on 26th Jul 2024
- Accessibility patent applications on February 6th, 2025
- Accessibility patent applications on July 25th, 2024
- Amazon technologies, inc. (20240301474). NUCLEASES FOR SIGNAL AMPLIFICATION simplified abstract
- Amazon Technologies, Inc. patent applications on September 12th, 2024
B
- Biotechnology patent applications on 10th Jan 2025
- Biotechnology patent applications on 21st Mar 2025
- Biotechnology patent applications on 28th Feb 2025
- Biotechnology patent applications on 5th Jul 2024
- Biotechnology patent applications on 7th Mar 2025
- Biotechnology patent applications on August 8th, 2024
- Biotechnology patent applications on February 27th, 2025
- Biotechnology patent applications on January 23rd, 2025
- Biotechnology patent applications on January 2nd, 2025
- Biotechnology patent applications on January 9th, 2025
- Biotechnology patent applications on July 4th, 2024
- Biotechnology patent applications on March 20th, 2025
- Biotechnology patent applications on March 6th, 2025
- Biotechnology patent applications on May 30th, 2024
- Biotechnology patent applications on October 3rd, 2024
- Blockchain patent applications on April 18th, 2024
- Blockchain patent applications on April 4th, 2024
- Blockchain patent applications on January 11th, 2024
- Blockchain patent applications on March 14th, 2024
- Blockchain patent applications on May 16th, 2024
C
- C-LEcta GmbH (20250092372). NUCLEASE HAVING IMPROVED SALT TOLERANCE AND/OR TEMPERATURE PERFORMANCE
- CANON KABUSHIKI KAISHA patent applications on January 25th, 2024
- Celex Oncology Innovations Limited (20250092399). GENE THERAPY TARGETING THE NEONATAL FORM OF NAV1.5 FOR TREATING CANCER
- Construction Tech patent applications on 23rd Aug 2024
- Construction Tech patent applications on August 22nd, 2024
D
F
I
T
- The regents of the university of california (20240252678). SYNTHETIC EXOSOMES (SE) FOR CNS DELIVERY OF CRISPR FOR GENE EDITING IN BRAIN DISORDERS simplified abstract
- The regents of the university of california (20240293578). METHODS OF TREATING MITOCHONDRIAL DISORDERS simplified abstract
- The regents of the university of california (20240299586). NOVEL AAV SEROTYPES DERIVED FROM A LIBRARY SCREEN simplified abstract
- The regents of the university of california (20240301017). METHODS OF TREATING MITOCHONDRIAL DISORDERS simplified abstract
- The regents of the university of california (20240301376). CLASS 2 CRISPR/CAS COMPOSITIONS AND METHODS OF USE simplified abstract
- The regents of the university of california (20240309345). COMPOSITIONS AND METHODS FOR GENE EDITING simplified abstract
- The regents of the university of california (20240409959). GENE DRIVE SYSTEM AND METHOD OF USE THEREOF
- The regents of the university of california (20250066803). METHODS FOR IMPROVING PROTEIN DELIVERY TO PLANT CELLS BY BIOLISTICS
- The Regents of the University of California (20250092373). CRISPR-MEDIATED DELETION OF FLI1 IN NK CELLS
- The regents of the university of california (20250092373). CRISPR-MEDIATED DELETION OF FLI1 IN NK CELLS
- The regents of the university of california (20250092391). PROMOTERS FOR VIRAL-BASED GENE THERAPY
- The Regents of the University of California patent applications on August 1st, 2024
- The Regents of the University of California patent applications on December 12th, 2024
- The Regents of the University of California patent applications on February 13th, 2025
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on February 27th, 2025
- The Regents of the University of California patent applications on March 20th, 2025
- The Regents of the University of California patent applications on September 12th, 2024
- The Regents of the University of California patent applications on September 19th, 2024
- The Regents of the University of California patent applications on September 5th, 2024
- TOYOTA JIDOSHA KABUSHIKI KAISHA patent applications on February 8th, 2024
U
- Unknown Organization (20240327889). REGULATION OF CELLS AND ORGANISMS simplified abstract
- US Patent Application 18248252. TYPE I CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS simplified abstract
- US Patent Application 18249865. NUCLEIC ACID-GUIDED NUCLEASES AND USE THEREOF simplified abstract
- US Patent Application 18303533. SITE SPECIFIC GENETIC ENGINEERING UTILIZING TRANS-TEMPLATE RNAS simplified abstract
- US Patent Application 18322675. SYSTEMS, METHODS, AND COMPOSITIONS FOR RNA-GUIDED RNA-TARGETING CRISPR EFFECTORS simplified abstract
- US Patent Application 18334046. TYPE VI CRISPR ORTHOLOGS AND SYSTEMS simplified abstract
- US Patent Application 18365040. HIGH-THROUGHPUT PRECISION GENOME EDITING simplified abstract
